Peptide-based diagnostic reagents for SARS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20050100883A1
SERIAL NO

10712812

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Calculated Rating
US Family Size
Non-US Coverage

Abstract

See full text

The present invention is directed to antigenic peptides and peptide compositions selected from the Membrane glycoprotein (M), the Spike glycoprotein (S), and the Nucleocapsid (N) protein antigens of the SARS coronavirus (SCoV). The present invention is also directed to methods of use of the peptides of the invention, e.g., for the detection of SARS-associated antibodies. Detection methods include enzyme-linked immunosorbent assay (ELISA) or other immunoassay procedures.

First Claim

See full text

Other Claims data not available

Family

PCTEP
+
−
  • No Family data available.

Patent Owner(s)

Patent OwnerAddress
UNITED BIOMEDICAL INC25 DAVIDS DRIVE HAUPPAUGE NY 11788

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Tseng Yuan West Islip, NY 2 13
Fang, Xinde Fresh Meadows, NY 2 13
Liu, Scott Lake Grove, NY 14 252
Lynn, Shugene Taoyuan, TW 6 36
Sia, Charles North York, CA 6 60
Wang, Chang Yi Cold Spring Harbor, NY 61 620

Cited Art Landscape

Load Citation

Patent Citation Ranking

  • 13 Citation Count
  • A61K Class
  • 62.00 % this patent is cited more than
  • 20 Age
Citation count rangeNumber of patents cited in rangeNumber of patents cited in various citation count ranges31718406143121428338222130144601 - 1011 - 2021 - 3031 - 4041 - 5051 - 6061 - 7071 - 8081 - 9091 - 100100 +010020030040050060070080090010001100120013001400150016001700180019002000

Forward Cite Landscape

Load Citation